Outcomes of kidney transplantation in recipients with SARS-cov-2 infection: a 282-case single-center experience in Japan
Authors:
- 3 October 2024
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 29 (2) , 182-191
Abstract
Background The coronavirus disease 2019, caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has become a global epidemic. There are concerns regarding the severity of SARS-CoV-2 infections in kidney transplant (KTx) recipients. However, there is limited data on how the epidemic has affected the treatment and prognosis of these patients. Therefore, we aimed to report the changes in the treatment and outcomes of KTx recipients infected with SARS-CoV-2 during each wave at our institution. Methods A total of 282 KTx recipients who were infected with SARS-CoV-2 during the study period were followed up at Tokyo Women’s Medical University between March 2020 and August 2022. We investigated the outcomes and treatments of infected KTx recipients. Results Nineteen (6.7%) patients showed severe outcomes, including eight SARS-CoV-2 infection-related deaths. Risk factors associated with severe outcomes included underlying conditions, such as diabetes mellitus, heart disease, and liver disease (odds ratios, 2.09, 2.88, and 5.52, respectively). Treatment strategies changed throughout the epidemic in response to changes in the SARS-CoV-2 variants. Antiviral drugs were gradually administered as soon as they were approved for use. Conclusions Treatment strategies for KTx recipients were gradually established over the course of the epidemic. Although the proportion of infected KTx recipients decreased compared to that of the general population throughout the epidemic, many patients still followed a severe course.Keywords
Funding Information
- MHLW Special Research Program (JPMH20CA2046)
- MHLW Research Program on Emerging and Reemerging Infectious Diseases (JPMH21HA2011)
This publication has 15 references indexed in Scilit:
- Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and WalesThe Lancet, 2022
- Impact of COVID‐19 on living donor liver and kidney transplantation programs in Japan in 2020Transplant Infectious Disease, 2022
- The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a PandemicTransplantation, 2022
- Excess mortality in solid organ transplant recipients hospitalized with COVID‐19: A large‐scale comparison of SOT recipients hospitalized with or without COVID‐19Clinical Transplantation, 2021
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant RecipientsJAMA, 2021
- COVID-19 in transplant recipients: The Spanish experienceAmerican Journal of Transplantation, 2021
- Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virusAmerican Journal of Transplantation, 2021
- Incidence, Characteristics, and Outcome of COVID-19 in Adults on Kidney Replacement Therapy: A Regionwide Registry StudyJournal of the American Society of Nephrology, 2020
- COVID-19 and Solid Organ Transplantation: A Review ArticleTransplantation, 2020
- Low prevalence and disease severity of COVID‐19 in post‐liver transplant recipients—A single centre experienceLiver International, 2020